Skip to content

Clinical trials

Lung Diseases, Interstitial trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Country / region: China Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20142
20151
20167
20174
20181
20195
20204
20213
20223
202310
20246
202510
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting19
Unknown status18
Completed16
Not yet recruiting6
Active, not recruiting5
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim7
Guangzhou Institute of Respiratory Disease4
Peking Union Medical College Hospital4
China-Japan Friendship Hospital3
GlaxoSmithKline3
The First Affiliated Hospital of Guangzhou Medical University3
Bristol-Myers Squibb2
Children's Hospital of Fudan University2
Kyntra Bio2
Qilu Hospital of Shandong University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial66
Pulmonary Fibrosis7
Connective Tissue Diseases6
Idiopathic Pulmonary Fibrosis6
Arthritis, Rheumatoid5
Pulmonary Disease, Chronic Obstructive5
Scleroderma, Diffuse4
Scleroderma, Systemic4
Idiopathic Interstitial Pneumonias3
Lung Diseases3

Trials

Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.